Kulis Jan, Wawrowski Łukasz, Sędek Łukasz, Wróbel Łukasz, Słota Łukasz, van der Velden Vincent H J, Szczepański Tomasz, Sikora Marek
Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, ul. 3 Maja 13-15, 41-800 Zabrze, Poland.
Łukasiewicz Research Network-Institute of Innovative Technologies EMAG, 40-189 Katowice, Poland.
J Clin Med. 2022 Apr 19;11(9):2281. doi: 10.3390/jcm11092281.
Flow cytometry technique (FC) is a standard diagnostic tool for diagnostics of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) assessing the immunophenotype of blast cells. BCP-ALL is often associated with underlying genetic aberrations, that have evidenced prognostic significance and can impact the disease outcome. Since the determination of patient prognosis is already important at the initial phase of BCP-ALL diagnostics, we aimed to reveal specific genetic aberrations by finding specific multiple antigen expression patterns with FC immunophenotyping. The FC immunophenotype data were analysed using machine learning methods (gradient boosting, decision trees, classification rules). The obtained results were verified with the use of repeated cross-validation. The t(12;21)/ETV6-RUNX1 aberration occurs more often when blasts present high expression of CD10, CD38, low CD34, CD45 and specific low expression of CD81. The t(v;11q23)/KMT2A is associated with positive NG2 expression and low CD10, CD34, TdT and CD24. Hyperdiploidy is associated with CD123, CD66c and CD34 expression on blast cells. In turn, high expression of CD81, low expression of CD45, CD22 and lack of CD123 and NG2 indicates that none of the studied aberrations is present. Detecting aberrations in pediatric BCP-ALL, based on the expression of multiple markers, can be done with decent efficiency.
流式细胞术(FC)是诊断B细胞前体急性淋巴细胞白血病(BCP-ALL)的标准诊断工具,用于评估原始细胞的免疫表型。BCP-ALL常与潜在的基因畸变相关,这些畸变已被证明具有预后意义,并可影响疾病结局。由于在BCP-ALL诊断的初始阶段确定患者预后就已经很重要,我们旨在通过FC免疫表型分析找到特定的多种抗原表达模式,以揭示特定的基因畸变。使用机器学习方法(梯度提升、决策树、分类规则)分析FC免疫表型数据。所得结果通过重复交叉验证进行验证。当原始细胞高表达CD10、CD38,低表达CD34、CD45以及CD81特异性低表达时,t(12;21)/ETV6-RUNX1畸变更常出现。t(v;11q23)/KMT2A与NG2阳性表达以及低CD10、CD34、TdT和CD24相关。超二倍体与原始细胞上的CD123、CD66c和CD34表达相关。相反,CD81高表达、CD45和CD22低表达以及缺乏CD123和NG2表明所研究的畸变均不存在。基于多种标志物的表达来检测儿童BCP-ALL中的畸变,可以达到相当高的效率。